Pyxis Oncology, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Pyxis Oncology, Inc. (PYXS) had Common Stock, Capital Shares Reserved for Future Issuance of 23.67 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-13
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 23.67M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 24.28M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 20.64M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 21.17M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 23.67M shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 24.28M shares 10-Q · filed 2026-05-14 | |
| 2025-12-31 | 20.64M shares 10-Q · filed 2026-08-13 | |
| 2025-09-30 | 21.17M shares 10-Q · filed 2025-11-03 | |
| 2025-06-30 | 21.30M shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 21.69M shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 19.66M shares 10-K · filed 2026-03-23 | |
| 2024-09-30 | 14.70M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 14.82M shares 10-Q · filed 2024-08-14 | |
| 2024-03-31 | 14.94M shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 12.20M shares 10-K · filed 2025-03-18 | 12.20M shares 10-K · filed 2024-03-21 |
| 2023-09-30 | 12.78M shares 10-Q · filed 2023-11-07 | |
| 2023-06-30 | 11.23M shares 10-Q · filed 2023-08-11 | |
| 2023-03-31 | 13.16M shares 10-Q · filed 2023-05-11 | |
| 2022-12-31 | 10.97M shares 10-K · filed 2024-03-21 | 11.19M shares 10-K · filed 2023-03-22 |
| 2022-09-30 | 10.97M shares 10-Q · filed 2022-11-01 | |
| 2022-06-30 | 9.67M shares 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 9.81M shares 10-Q · filed 2022-05-13 | |
| 2021-12-31 | 8.26M shares 10-K · filed 2023-03-22 | |
| 2021-09-30 | 28.42M shares 10-Q · filed 2021-11-15 | |
| 2020-12-31 | 4.72M shares 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |